Report copyright - VMAT-SBRT: Beneficio clínico-dosimétrico en cáncer ... · • RTOG 0617: Recidiva ganglionar N1 o N2 (primitivo T1-T2 N0 tratado con cirugía sin RT o CT adyuvante) ... Solda et
Please pass captcha verification before submit form
Please pass captcha verification before submit form